Consun Pharmaceutical Group Limited
CPHGF
$1.08
$0.0747.34%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 14.45% | 12.82% | 9.65% | 9.47% | 9.30% |
| Total Depreciation and Amortization | -19.44% | -8.84% | 0.84% | -1.11% | -3.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.03% | 84.62% | 113.40% | 87.81% | -426.24% |
| Change in Net Operating Assets | 994.28% | -16.06% | -109.36% | -109.36% | -109.36% |
| Cash from Operations | 31.73% | 16.99% | 1.48% | -8.55% | -17.75% |
| Capital Expenditure | -105.63% | -102.34% | -95.22% | -39.30% | 4.30% |
| Sale of Property, Plant, and Equipment | 116.75% | -16.24% | -41.70% | -69.78% | -88.23% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.32% | -248.71% | -1,044.20% | -85.14% | 50.13% |
| Cash from Investing | 17.87% | -188.50% | -57,159.26% | -74.74% | 43.71% |
| Total Debt Issued | 12.47% | 10.82% | 8.68% | 35.40% | 70.59% |
| Total Debt Repaid | -98.00% | -66.44% | -26.47% | -3.56% | 12.31% |
| Issuance of Common Stock | 906.86% | 1,065.72% | 1,312.51% | 1,116.76% | 438.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -103.77% | -126.93% | -162.15% | -151.63% | -135.60% |
| Other Financing Activities | 350.61% | 177.38% | -90.50% | -113.76% | -151.61% |
| Cash from Financing | -156.19% | -159.34% | -162.18% | -37.95% | 24.49% |
| Foreign Exchange rate Adjustments | -28.65% | -586.08% | -187.43% | -165.90% | -148.85% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.39% | -88.95% | -106.67% | -74.04% | 26.30% |